Abstract
The rapid expansion of telemedicine during the global COVID-19 pandemic left a lasting imprint on obstetric and gynaecological practice, transforming what had previously been a marginal service delivery model into a mainstream component of reproductive healthcare. A 2025 scoping review synthesising sixty-three peer-reviewed studies published between 2010 and 2023 mapped the principal modalities now in use, including synchronous video consultations, remote physiological monitoring, AI-assisted patient triage, tele-supervision of trainees, and asynchronous store-and-forward communication [1].
References
This work is licensed under a Creative Commons Attribution 4.0 International License.